John W. LaRocca - 06 Jan 2025 Form 3 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
16 Jan 2025, 16:44:32 UTC
Prior SEC filing
21 Nov 2022
Next SEC filing
22 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John LaRocca
Filing notes and source

Key filing fact

John W. LaRocca filed Form 3 for Y-mAbs Therapeutics, Inc. (YMAB) on 16 Jan 2025.

Key facts

  • This page summarizes John W. LaRocca's Form 3 filing for Y-mAbs Therapeutics, Inc. (YMAB).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 16 Jan 2025, 16:44.

Change

  • Previous filing in this sequence was filed on 21 Nov 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

YMAB holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
06 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
142,600
Exercise price
$9.83
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option shall vest and become exercisable as to 25% of the shares subject to the option on January 18, 2025, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .